Inhibikase Therapeutics, Inc. (IKT) — key valuation metrics and fundamentals.
See the full interactive analysis →
Fair value compares IKT's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Nov 2026.